Oxarane-Acrylate System to Double the Clinical Service Life of Restorative Resins
Oxarane-Acrylate System to Double the Clinical Service Life of Restorative Resins
批准号:
9130154
负责人:
H. RALPH RAWLS
金额:
$35.86万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-09-01 至 2018-08-31
关键词:
AccountingAcrylatesAddressAnimalsAnti-Bacterial AgentsAwardBacteriaBiochemicalBiocompatible MaterialsBiomedical EngineeringBisphenol A-Glycidyl MethacrylateCalciumCharacteristicsChemical EngineeringClinicalClinical ResearchClinical ServicesColorComposite Dental ResinDelayed HypersensitivityDentalDental EnamelDental PulpDental cariesDentinDentistryDoctor of PhilosophyEnvironmentEstersEthylene OxideEventExposure toFatigueFillerFluorineGoalsHealthHydrolysisHydrophobicityHydroquinonesHypersensitivityIn SituIn VitroIncidenceIonsLifeLongevityMasticationMechanicsMethacrylatesMicrobial BiofilmsMineralsModelingNatureOne-Step dentin bonding systemOralOral cavityOral healthOral mucous membrane structureOxygenPerformancePlant ResinsPolymer ChemistryPolymersPredispositionPropertyRecurrenceRelaxationResidual stateResistanceScientistSideSilverSolidStressStructureSurfaceSystemTestingUrethaneViscosityWaterWorkanalogantimicrobialbacterial resistancebasebiomaterial compatibilitybisphenol Acostcrosslinkdental resindesigndioxiraneesterasein vivoinnovationinorganic phosphateirritationmaterials sciencemeetingsmonomermultidisciplinarynanoparticlenovelphysical propertypolymerizationresponserestorationrestorative dentistryrestorative resinstriethylene glycol dimethacrylateuptake
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): In order to develop a novel restorative system with at least twice the lifetime of Bis-GMA/TEGDMA- based composites, their incomplete cure and susceptibility to hydrolysis and esterase degradation must be overcome. To address these problems, we will develop a novel superhydrophobic, degradation-resistant, dental restorative based on an Oxirane/Acrylate interpenetrating network System (OASys, pronounced Oasis). These novel monomers based on fluoridated urethanes with either dioxirane or diacrylate functionality can be highly converted to form a hydrophobic, degradation-resistant, tough and resilient interpenetrating polymer network (IPN) that is inherently highly crosslinked. By their nature, these characteristics impart low residual stresses, high resistance to hydrolytic and enzymatic degradation, and biocompatibility. We will also develop a novel one-step (primer-less), "smart," antimicrobial bonding resin with in situ-generated, colorless and color stable, silver nanoparticles (AgNPs). The bonding resin will contain a phosphate group plus both oxirane and acrylate functionalities. The oxirane and acrylate functionalities bond to the corresponding functionalities in the IPN resin matrix for potentially a much stronger bond than the conventional methacrylate system. The phosphate group will allow the bonding resin to wet etched mineral surfaces as well as bond directly to calcium in Ca-phosphate mineral structures. In the event of marginal gap formation, the "smart" in situ-generated AgNPs will release Ag+ ions and create an antibacterial environment, thereby further reducing the incidence of recurrent caries. Five specific aims are proposed: 1. To determine the effect of using oxiranes, increased hydrophobicity, and IPNs on resin mechanical properties, physical properties and in vitro biocompatibility. The more promising compositions will be combined with reinforcing filler and used for Aim 2. 2. To determine the effect of using a 4- Phospho-NPG GA oxirane (4POA)-based bonding system and in situ-generated silver nanoparticles (AgNP) on bonding resin mechanical properties, physical properties, and in vitro biocompatibility and antibacterial activit, as well as on bond strength to oxirane/acrylate interpenetrating network composites. The two best- performing composites will be chosen for subsequent aims. 3. To determine the effect of using oxiranes, increased hydrophobicity, and IPNs on resin resistance to the oral biochemical environment. The two best- performing groups chosen in Aim 2 will be fatigue- and wear-tested after exposure to acidic, basic and esterase-containing environments for 90 days. 4. To determine the effect of using oxiranes, increased hydrophobicity, and IPNs on resin resistance to bacterial degradation. The two best-performing groups from Aim 2 will be tested in an artificial
mouth bacterial biofilm model. 5. To determine the in vivo biocompatibility of the OASys. The best performing OASys will be tested in three in vivo biocompatibility models: delayed-type hypersensitivity, oral mucosa irritation, and pulp and dentin response tests.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Oxarane-Acrylate System to Double the Clinical Service Life of Restorative Resins
-
批准号:8729445
-
项目类别:
-
资助金额:$44.25万
-
财政年份:2013
-
负责人:H. RALPH RAWLS
-
依托单位:
Oxarane-Acrylate System to Double the Clinical Service Life of Restorative Resins
-
批准号:8610770
-
项目类别:
-
资助金额:$43.7万
-
财政年份:2013
-
负责人:H. RALPH RAWLS
-
依托单位:
Nanoparticles and Composites
-
批准号:6915792
-
项目类别:
-
资助金额:$15.23万
-
财政年份:2004
-
负责人:H. RALPH RAWLS
-
依托单位:
Nanoparticles and Composites
-
批准号:6754569
-
项目类别:
-
资助金额:$15.06万
-
财政年份:2003
-
负责人:H. RALPH RAWLS
-
依托单位:
Antimicrobial Coating for Biofilm Inhibition
-
批准号:6485882
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2002
-
负责人:H. RALPH RAWLS
-
依托单位:
Novel Vehicle for Topical Delivery of Corticosteroids
-
批准号:6549778
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2002
-
负责人:H. RALPH RAWLS
-
依托单位:
NANOFILLER DEVELOPMENT
-
批准号:6443359
-
项目类别:
-
资助金额:$40.85万
-
财政年份:2001
-
负责人:H. RALPH RAWLS
-
依托单位:
NANOFILLER DEVELOPMENT
-
批准号:6395831
-
项目类别:
-
资助金额:$20.59万
-
财政年份:2000
-
负责人:H. RALPH RAWLS
-
依托单位:
NANOFILLER DEVELOPMENT
-
批准号:6217542
-
项目类别:
-
资助金额:$20.59万
-
财政年份:1999
-
负责人:H. RALPH RAWLS
-
依托单位:
NANOFILLER DEVELOPMENT
-
批准号:6104909
-
项目类别:
-
资助金额:$16.8万
-
财政年份:1999
-
负责人:H. RALPH RAWLS
-
依托单位:
NANOFILLER DEVELOPMENT
-
批准号:6270349
-
项目类别:
-
资助金额:$20.74万
-
财政年份:1998
-
负责人:H. RALPH RAWLS
-
依托单位:
ADVANCED DENTAL RESTORATIVE SYSTEMS
-
批准号:2015214
-
项目类别:
-
资助金额:$70.16万
-
财政年份:1997
-
负责人:H. RALPH RAWLS
-
依托单位:
Drug Delivery System for Superficial Mycoses
-
批准号:6406028
-
项目类别:
-
资助金额:$36.54万
-
财政年份:1997
-
负责人:H. RALPH RAWLS
-
依托单位:
ADVANCED DENTAL RESTORATIVE SYSTEMS
-
批准号:2897089
-
项目类别:
-
资助金额:$67.2万
-
财政年份:1997
-
负责人:H. RALPH RAWLS
-
依托单位:
ADVANCED DENTAL RESTORATIVE SYSTEMS (ADRS)
-
批准号:6659039
-
项目类别:
-
资助金额:$114.69万
-
财政年份:1997
-
负责人:H. RALPH RAWLS
-
依托单位:
Nanoparticles and Composites
-
批准号:6443097
-
项目类别:
-
资助金额:$16.4万
-
财政年份:1997
-
负责人:H. RALPH RAWLS
-
依托单位:
DRUG DELIVERSY SYSTEM FOR SUPERFICIAL MYCOSES IN AIDS
-
批准号:2417546
-
项目类别:
-
资助金额:$10.0万
-
财政年份:1997
-
负责人:H. RALPH RAWLS
-
依托单位:
ADVANCED DENTAL RESTORATIVE SYSTEMS (ADRS)
-
批准号:6754509
-
项目类别:
-
资助金额:$117.54万
-
财政年份:1997
-
负责人:H. RALPH RAWLS
-
依托单位:
ADVANCED DENTAL RESTORATIVE SYSTEMS
-
批准号:6176084
-
项目类别:
-
资助金额:$64.3万
-
财政年份:1997
-
负责人:H. RALPH RAWLS
-
依托单位:
NANOFILLER DEVELOPMENT
-
批准号:6440214
-
项目类别:
-
资助金额:$7.29万
-
财政年份:1997
-
负责人:H. RALPH RAWLS
-
依托单位:
海外基金